We are live on
!
Find out more
CLCM
Crawford Lake Capital Management Portfolio holdings
AUM
$87.4M
1-Year Est. Return
30.13%
This Fund
S&P 500
This Quarter
Est. Return
+27.06%
1 Year Est. Return
+30.13%
3 Year Est. Return
+571.16%
5 Year Est. Return
+2,274.1%
10 Year Est. Return
–
AUM
$424M
AUM Growth
+$145M
(+52%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
25.61%
Top 10 Holdings %
Top 10 Hldgs %
45.94%
Holding
101
New
45
Increased
9
Reduced
4
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$24.3M |
| 2 |
XYZ
Block Inc
XYZ
|
+$21M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$20.2M |
| 4 |
Intel
INTC
|
+$15.1M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBIS
Nebius Group N.V.
NBIS
|
+$16M |
| 2 |
Advanced Micro Devices
AMD
|
+$10.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$8.1M |
| 4 |
Baidu
BIDU
|
+$7.41M |
| 5 |
Palo Alto Networks
PANW
|
+$7.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.3% |
| 2 | Healthcare | 22.51% |
| 3 | Communication Services | 10.01% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Financials | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$16.6B
| $4.66M | 1.1% |
+60,001
| New | +$4.09M |
|
|
ZGNX
27
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $4.57M | 1.08% |
114,200
+59,200
| +108% | +$2.27M |
|
|
LOXO
28
DELISTED
Loxo Oncology, Inc
LOXO
| $4.5M | 1.06% |
53,420
-28,305
| -35% | -$2.36M |
|
29
Marvell Technology
MRVL
$196B
| $4.44M | 1.05% |
+206,861
| New | +$4.22M |
|
30
Aptiv
APTV
$10.3B
| $4.23M | 1% |
+49,875
| New | +$4.75M |
|
|
RVNC
31
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.21M | 0.99% |
+117,666
| New | +$3.38M |
|
32
JD.com
JD
$44.5B
| $4.13M | 0.98% |
+99,789
| New | +$3.93M |
|
33
Vipshop
VIPS
$7.53B
| $4.13M | 0.97% |
+352,076
| New | +$3.11M |
|
|
34
CALL
Neurocrine Biosciences
NBIX
$16.6B
| $4.04M | 0.95% |
+52,000
| New | +$3.55M |
|
35
State Street SPDR S&P Regional Banking ETF
KRE
$4.57B
| $3.94M | 0.93% |
+66,887
| New | +$3.84M |
|
36
CALL
Exelixis
EXEL
$13.4B
| $3.93M | 0.93% |
+129,300
| New | +$3.44M |
|
|
37
CALL
JD.com
JD
$44.5B
| $3.77M | 0.89% |
+91,100
| New | +$3.58M |
|
38
BlackBerry
BB
$5.26B
| $3.5M | 0.83% |
313,249
+206,762
| +194% | +$2.26M |
|
|
39
Exelixis
EXEL
$13.4B
| $3.44M | 0.81% |
+113,311
| New | +$3.01M |
|
40
CALL
Centene
CNC
$32.5B
| $3.15M | 0.74% |
+62,400
| New | +$3.02M |
|
41
Jacobs Solutions
J
$17B
| $3.12M | 0.74% |
+57,231
| New | +$2.94M |
|
|
KMG
42
DELISTED
KMG Chemicals Inc
KMG
| $3.09M | 0.73% |
+46,793
| New | +$2.65M |
|
43
Bank of America
BAC
$442B
| $2.97M | 0.7% |
+100,614
| New | +$2.77M |
|
44
Amazon
AMZN
$2.96T
| $2.34M | 0.55% |
40,000
-26,740
| -40% | -$1.47M |
|
|
GWPH
45
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.24M | 0.53% |
+17,000
| New | +$2M |
|
|
PENG
46
Penguin Solutions Inc
PENG
$2.99B
| $2.14M | 0.51% |
+127,260
| New | +$2.02M |
|
|
47
PUT
JD.com
JD
$44.5B
| $2.09M | 0.49% |
+50,500
| New | +$1.99M |
|
|
KMG
48
CALL
DELISTED
KMG Chemicals Inc
KMG
| $1.84M | 0.44% |
+27,900
| New | +$1.58M |
|
49
Mercado Libre
MELI
$92.3B
| $1.65M | 0.39% |
+5,242
| New | +$1.42M |
|
50
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
| $1.57M | 0.37% |
+56,359
| New | +$1.52M |
|
Similar funds
BO
BC
PAM
S
RLKPA
MA
BU
CFS
Crawford Lake Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Crawford Lake Capital Management held 101 positions worth $424M, up 52% from $279M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Crawford Lake Capital Management deployed $109M of net new capital in Q4 2017, opening 45 new positions and adding to 9 existing holdings. Its largest new stake was Block Inc: 574,437 shares worth $19.9M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $8.1M trimmed.
- Crawford Lake Capital Management's largest Q4 2017 buy was Block Inc: 574,437 shares worth $19.9M.
- Crawford Lake Capital Management added most to Alphabet (Google) Class C in Q4 2017, an estimated $24.3M increase.
- Crawford Lake Capital Management's biggest Q4 2017 reduction was Vertex Pharmaceuticals, cutting an estimated $8.1M.
- Crawford Lake Capital Management fully exited Nebius Group N.V. in Q4 2017, selling an estimated $16M.
- Crawford Lake Capital Management's ten largest holdings make up 46% of its $424M portfolio in Q4 2017.
- Crawford Lake Capital Management opened 45 new positions and closed 43 in Q4 2017.
- Crawford Lake Capital Management's portfolio value rose 52% quarter-over-quarter to $424M.
Based on Crawford Lake Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.